Skip to main content
Clinical Trials/NL-OMON43296
NL-OMON43296
Completed
Not Applicable

The microbiome of Q Fever Fatigue Syndrome (QFS) - Microbiome of QFS

Algemene Interne Geneeskunde0 sites90 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Algemene Interne Geneeskunde
Enrollment
90
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Algemene Interne Geneeskunde

Eligibility Criteria

Inclusion Criteria

  • Healthy controls (n\=30\)
  • \- Female gender
  • \- Age between 18 and 59 years old;QFS patients (n\=30\)
  • \- Female gender
  • \- Age between 18 and 59 years old
  • \- LCI guideline on QFS diagnosis of QFS
  • \- Score \>\=40 on the subscale fatigue of the Checklist Individual Strength (CIS) at time of diagnosis
  • \- Severe functional impairment on Sickness Impact Profile\-8 (SIP\-8\), defined as a SIP total score \>\=700 at time of diagnosis
  • \- Fatigue duration for under 10 years;CFS patients (n\=30\)
  • \- Female gender

Exclusion Criteria

  • Healthy controls (n\=30\)
  • \- No pregnancy / nursing
  • \- No somatic or psychiatric comorbidity
  • \- No complaints of fatigue (no complaints on lifestyle questionnaires)
  • \- No use of medication in the last month (except oral contraceptives and / or paracetamol
  • \- No vaccination during the last month before the study
  • \- No substance abuse in the last 3 months before the study
  • \- No history of Q fever, tested with serology;QFS patients (n\=30\)
  • \- No pregnancy / nursing
  • \- No somatic or psychiatric comorbidity

Outcomes

Primary Outcomes

Not specified

Similar Trials